May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
CHARACTERIZATION OF NEOVASCULAR RESPONSES IN TRANSGENIC MICE WITH TISSUE–SPECIFIC OVEREXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR
Author Affiliations & Notes
  • W.–Y. Shen
    Department of Molecular Ophthalmology, Lions Eye Institute, Perth, Australia
  • C.–M. Lai
    Centre for Ophthalmology and Visual Science,
    University of Western Australia, Perth, Australia
  • N. Binz
    Department of Molecular Ophthalmology, Lions Eye Institute, Perth, Australia
  • I.J. Constable
    Centre for Ophthalmology and Visual Science,
    University of Western Australia, Perth, Australia
  • S.A. Dunlop
    Department of Zoology,
    University of Western Australia, Perth, Australia
  • L.D. Beazley
    Department of Zoology,
    University of Western Australia, Perth, Australia
  • P.E. Rakoczy
    Centre for Ophthalmology and Visual Science,
    University of Western Australia, Perth, Australia
  • Footnotes
    Commercial Relationships  W. Shen, None; C. Lai, None; N. Binz, None; I.J. Constable, None; S.A. Dunlop, None; L.D. Beazley, None; P.E. Rakoczy, None.
  • Footnotes
    Support  NHMRC/JDRF (USA) 219166
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 453. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      W.–Y. Shen, C.–M. Lai, N. Binz, I.J. Constable, S.A. Dunlop, L.D. Beazley, P.E. Rakoczy; CHARACTERIZATION OF NEOVASCULAR RESPONSES IN TRANSGENIC MICE WITH TISSUE–SPECIFIC OVEREXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR . Invest. Ophthalmol. Vis. Sci. 2004;45(13):453.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To characterize transgenic mice with overexpression of vascular endothelial growth factor (VEGF) in photoreceptors for a model of diabetic retinopathy.Methods: Opsin–VEGF transgenic mice were examined by fundus fluorescein angiography and fluorescence microscopy after perfusion with fluorescence–labelled dextran (FITC–dextran). The flat mount preparations perfused with FITC–dextran were also incubated with rat monoclonal antibodies to mouse Ki–67 and CD105 for doubling labelling to identify proliferating cells and activated vascular endothelial cells during retinal neovascularization. Results:Fundus fluorescein angiography revealed both mild and severe proliferative retinopathy in opsin–VEGF transgenic mice. Fluorescence microscopy of FITC–dextran–perfused retinas demonstrated intraretinal microaneurysm and mild neovascularization in the deep capillary bed in mild cases, and massive development of retinal and/or subretinal neovascularization in severe cases. Histology further confirmed these vascular abnormalities. The severities of retinal neovascularization were well correlated with the number of cells expressing Ki–67 and CD105.Conclusions: Our opsin–VEGF transgenic mice present retinal neovascular changes similar to different stages of diabetic retinopathy, which are useful for development of new strategies for treatment of diabetic retinopathy.

Keywords: retinal neovascularization • transgenics/knock–outs • diabetic retinopathy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×